Search This Blog

Monday, April 8, 2019

Kiniksa to present preclinical KPL-404 data at Keystone Symposia

Kiniksa announced that it will present preclinical data for KPL-404, a monoclonal antibody inhibitor of the CD40 co-stimulatory receptor, at the Keystone Symposia.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)